Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMX3CNS)

Drug Name

StarGen Drug Info

Synonyms

Juvenile degenerative retinal disease therapy, Oxford BioMedica; ABCR gene therapy (Stargardt disease, LentiVector), Oxford BioMedica

Indication

Disease Entry	ICD 11	Status	REF
Retinitis pigmentosa	9B70	Phase 1/2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
ATP-binding cassette transporter A4 (ABCA4)	TTLB52K	ABCA4_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01736592) A Study to Determine the Long Term Safety, Tolerability and Biological Activity of StarGen in Patients With Stargardt's Macular Degeneration. U.S. National Institutesof Health.
2	Clinical pipeline report, company report or official report of Oxford BioMedica.